These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8273986)

  • 1. Glycogen storage disease in adults.
    Talente GM; Coleman RA; Alter C; Baker L; Brown BI; Cannon RA; Chen YT; Crigler JF; Ferreira P; Haworth JC; Herman GE; Issenman RM; Keating JP; Linde R; Roe TF; Senior B; Wolfsdorf JI
    Ann Intern Med; 1994 Feb; 120(3):218-26. PubMed ID: 8273986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
    Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.
    Yekeler E; Dursun M; Emeksiz E; Akkoyunlu M; Akyol Y; Demir F; Gökcay G; Demirkol M
    Turk J Pediatr; 2007; 49(2):115-9. PubMed ID: 17907509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using
    Turki A; Stockler S; Sirrs S; Duddy K; Ho G; Elango R
    Mol Genet Metab Rep; 2023 Mar; 34():100955. PubMed ID: 36632325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?
    Colonetti K; Pinto E Vairo F; Siebert M; Nalin T; Poloni S; Fernando Wurdig Roesch L; Fischinger Moura de Souza C; Cabral Pinheiro F; Vanessa Doederlein Schwartz I
    Cytokine; 2023 Feb; 162():156088. PubMed ID: 36462220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).
    Rake JP; Visser G; Labrune P; Leonard JV; Ullrich K; Smit GP
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S20-34. PubMed ID: 12373567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for glycogen storage disease types I, III, and IV.
    Matern D; Starzl TE; Arnaout W; Barnard J; Bynon JS; Dhawan A; Emond J; Haagsma EB; Hug G; Lachaux A; Smit GP; Chen YT
    Eur J Pediatr; 1999 Dec; 158 Suppl 2(Suppl 2):S43-8. PubMed ID: 10603098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study.
    Chan YC; Liu KM; Chen CL; Ong AD; Lin CC; Yong CC; Tsai PC; Lu LS; Wu JY
    Orphanet J Rare Dis; 2021 Oct; 16(1):423. PubMed ID: 34635148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle Ultrasound in Patients with Glycogen Storage Disease Types I and III.
    Verbeek RJ; Sentner CP; Smit GP; Maurits NM; Derks TG; van der Hoeven JH; Sival DA
    Ultrasound Med Biol; 2016 Jan; 42(1):133-42. PubMed ID: 26437929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.
    Chen YT
    Pediatr Nephrol; 1991 Jan; 5(1):71-6. PubMed ID: 2025544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.
    Matern D; Seydewitz HH; Bali D; Lang C; Chen YT
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S10-9. PubMed ID: 12373566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for glycogen storage disease type Ia.
    Reddy SK; Austin SL; Spencer-Manzon M; Koeberl DD; Clary BM; Desai DM; Smith AD; Kishnani PS
    J Hepatol; 2009 Sep; 51(3):483-90. PubMed ID: 19596478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
    Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen storage diseases in Thai patients: Phramongkutklao Hospital experience.
    Kamolsilp M
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S295-301. PubMed ID: 16858972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease in glycogen storage disease type Ib.
    Roe TF; Thomas DW; Gilsanz V; Isaacs H; Atkinson JB
    J Pediatr; 1986 Jul; 109(1):55-9. PubMed ID: 3459848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX.
    Geberhiwot T; Alger S; McKiernan P; Packard C; Caslake M; Elias E; Cramb R
    J Inherit Metab Dis; 2007 Jun; 30(3):406. PubMed ID: 17407002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX.
    Cabrera-Abreu J; Crabtree NJ; Elias E; Fraser W; Cramb R; Alger S
    J Inherit Metab Dis; 2004; 27(1):1-9. PubMed ID: 14970741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.